[Chemotherapy of malignant melanoma].
Avril
M F
MF
Service de Dermatologie, Institut Gustave-Roussy, Villejuif.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008130:Lomustine / Q000008:administration & dosage; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary / Q000628:therapy; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000628:therapy; D013629:Tamoxifen / Q000627:therapeutic use
D007376:Interleukin-2; D013629:Tamoxifen; C027168:5-(3,3-dimethyl-1-triazeno)-1-methylimidazole-4-carboxamide; D008130:Lomustine; D003606:Dacarbazine; D007372:Interferons
Chimiothérapie du mélanome malin.